- Rheumatoid Arthritis
(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
If you are 18 or older, have histologically confirmed Stage IV melanoma, a life expectancy of greater than 12 weeks, and are willing to provide informed consent, you may be eligible for this study.
The research site is in Robbinsdale, Minn.
If you are aged 21 to 41 and have a normal uterine cavity, you may qualify for this study.
The research site is in Hackensack, N.J.
If you are 18 or older, have had active rheumatoid arthritis for at least six months, and have received permitted DMARDs at a stable dose for at least seven weeks, you may qualify for this study.
The research site is in Beckley, WV
Copyright 2008 CenterWatch. All rights reserved.
Copyright © 2011 HealthDay. All rights reserved.